This discovery, described online in the April 25 edition of eLife, will lead to important research and may one day help experts develop new and better therapies for Alzheimer's and other forms of cognitive decline.
Using human skin cells, University of California, Irvine neurobiologists and their colleagues have created a method to generate one of the principle cell types of the brain called microglia, which play a key role in preserving the function of neural networks and responding to injury and disease.
New discoveries tied to how food affects our body and why we make certain food choices could help inform nutrition plans and policies that encourage healthy food choices. The Experimental Biology 2017 meeting will showcase groundbreaking research in food policy, nutrition and the biochemistry of food.
ASU production breaks new ground for science communication
Tangles of the protein tau dot the brains of people with diseases like Alzheimer’s. Now, researchers have found a way to measure tau in the blood that accurately reflects tau in the brain. The study, in mice and a small group of people, could be the first step towards a non-invasive test for tau.
Saint Louis University scientist Yuna Ayala, Ph.D., and her research team have made advances in understanding how damaging plaques build up in neurodegenerative illnesses like ALS and dementia.
A new study published in Frontiers in Aging Neuroscience finds the so-called brain games of the growing billion-dollar brain-training industry do little to improve or protect cognitive performance.
Music and voice major Jessica Voutsinas ’18 was singing the classic song “Over the Rainbow” to a resident at Longview — an adult residential facility near the Ithaca College campus — when the woman unexpectedly lit up and began telling stories about her life and children in a breakthrough of memory recall.
A new study published this week in the journal Proceedings of the National Academy of Sciences refines our understanding of a human skill — the ability to instantaneously assess a new environment and get oriented thanks to visual cues.
UAB physicians say prevention, not cure, may be the key to coping with the rising incidence of Alzheimer's disease. New imaging techniques, coupled with a better understanding of the disease, provide new hope.
Unique graphic characters called Greebles may prove to be valuable tools in detecting signs of Alzheimer’s disease decades before symptoms become apparent.
A new study has found a link between neurological birth defects in infants commonly found in pregnant women with diabetes and several neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s diseases. This is the first time this link has been identified; it may indicate a new way to understand, and perhaps treat, both neural tube defects and these neurodegenerative diseases.
EyesOnALZ (http://eyesonalz.com) – a project to crowdsource Alzheimer’s research is launching an online competition to #CrushALZ on April 6th, in partnership with The Crowd & The Cloud – a public television documentary series about citizen science.
The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.
A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT) – a testosterone-lowering therapy and a common treatment for the disease – and dementia, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
In experiments with a protein called Ephexin5 that appears to be elevated in the brain cells of Alzheimer's disease patients and mouse models of the disease, Johns Hopkins researchers say removing it prevents animals from developing Alzheimer's characteristic memory losses. In a report on the studies, published online March 27 in The Journal of Clinical Investigation, the researchers say the findings could eventually advance development of drugs that target Ephexin5 to prevent or treat symptoms of the disorder.
Neurologists at the Rush Alzheimer’s Disease Center are conducting an 18-month clinical trial testing a type of insulin delivered in a nasal spray – which is used to treat diabetes in some patients – in the Study of Nasal Insulin to Fight Forgetfulness (SNIFF).
Investigators at Rush University Medical Center and the Brigham and Women’s Hospital in Boston reported the discovery of a new gene that is associated with susceptibility to a common form of brain pathology called Tau that accumulates in several different conditions, including Alzheimer’s disease, certain forms of dementia and Parkinsonian syndromes as well as chronic traumatic encephalopathy that occurs with repeated head injuries.
The American Academy of Neurology is awarding two California researchers the 2017 Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases for their work in dementia research. Claudia Kawas, MD, of the University of California, Irvine, and Kristine Yaffe, MD, of the University of California, San Francisco, both members of the American Academy of Neurology, will be honored at the American Academy of Neurology’s 69th Annual Meeting in Boston.
Thin parts of the cell membranes of neurons turn out to be particularly vulnerable to a protein that collects in the brain of people with Alzheimer's disease, according to a University of Michigan researcher.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right